Lithium ameliorates altered glycogen synthase kinase-3 and behavior in a mouse model of Fragile X syndrome
- 15 February 2010
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 79 (4), 632-646
- https://doi.org/10.1016/j.bcp.2009.09.023
Abstract
No abstract availableKeywords
Funding Information
- FRAXA Research Foundation
- Evelyn F. McKnight Brain Research Foundation
- NIH (MH38752, MH57014)
This publication has 64 references indexed in Scilit:
- Dissociation of social and nonsocial anxiety in a mouse model of fragile X syndromeNeuroscience Letters, 2009
- Elevated glycogen synthase kinase-3 activity in Fragile X mice: Key metabolic regulator with evidence for treatment potentialNeuropharmacology, 2008
- Unaltered hormonal response to stress in a mouse model of fragile X syndromePsychoneuroendocrinology, 2008
- Rescue of behavioral phenotype and neuronal protrusion morphology in Fmr1 KO miceNeurobiology of Disease, 2008
- Correction of Fragile X Syndrome in MiceNeuron, 2007
- Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEPNeuropharmacology, 2005
- Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X SyndromeNeuron, 2005
- The mGluR theory of fragile X mental retardationTrends in Neurosciences, 2004
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Absence of expression of the FMR-1 gene in fragile X syndromeCell, 1991